Paper41368640
Mast cell metabolism in cancer: an underexplored frontier demanding more attention.
Frossi B and 3 others. Front Immunol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Mast cell metabolism in cancer: an underexplored frontier demanding more attention. Papers, record 41368640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41368640
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mast Cells | Major topic |
| Neoplasms | Major topic |
| Energy Metabolism | Major topic |
| Humans | |
| Tumor Microenvironment | |
| Animals | |
| Glucose |
Source PubMed
References235
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37531900 | Blocking LTB4 signaling-mediated TAMs recruitment by Rhizoma Coptidis sensitizes lung cancer to immunotherapy. | Phytomedicine | 2023 | https://conductscience.org/library/papers/37531900 | PubMed |
| 2 | 27559047 | Lactic Acid Suppresses IL-33-Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1α-Dependent miR-155 Suppression. | J Immunol | 2016 | https://conductscience.org/library/papers/27559047 | PubMed |
| 3 | 36170813 | Mast cell regranulation requires a metabolic switch involving mTORC1 and a glucose-6-phosphate transporter. | Cell Rep | 2022 | https://conductscience.org/library/papers/36170813 | PubMed |
| 4 | 4174120 | Further observations on the inhibition of histamine release by 2-deoxyglucose. | Acta Physiol Scand | 1968 | https://conductscience.org/library/papers/4174120 | PubMed |
| 5 | 16127161 | Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. | Am J Pathol | 2005 | https://conductscience.org/library/papers/16127161 | PubMed |
| 6 | 26321679 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. | Cell | 2015 | https://conductscience.org/library/papers/26321679 | PubMed |
| 7 | 39178229 | Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39178229 | PubMed |
| 8 | 29445756 | Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor. | J Immunol Res | 2017 | https://conductscience.org/library/papers/29445756 | PubMed |
| 9 | 36229606 | Metabolic communication in the tumour-immune microenvironment. | Nat Cell Biol | 2022 | https://conductscience.org/library/papers/36229606 | PubMed |
| 10 | 29248131 | Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. | Semin Oncol | 2017 | https://conductscience.org/library/papers/29248131 | PubMed |
| 11 | 28462845 | Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses. | Trends Immunol | 2017 | https://conductscience.org/library/papers/28462845 | PubMed |
| 12 | 33301708 | Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity. | Cell | 2020 | https://conductscience.org/library/papers/33301708 | PubMed |
| 13 | 19643985 | Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation. | Blood | 2009 | https://conductscience.org/library/papers/19643985 | PubMed |
| 14 | 37430087 | MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37430087 | PubMed |
| 15 | 34439898 | Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets. | Biomolecules | 2021 | https://conductscience.org/library/papers/34439898 | PubMed |
| 16 | 37746665 | Arachidonic acid metabolism in health and disease. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/37746665 | PubMed |
| 17 | 17606905 | Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17606905 | PubMed |
| 18 | 29597213 | The Staining of Mast Cells: A Historical Overview. | Int Arch Allergy Immunol | 2018 | https://conductscience.org/library/papers/29597213 | PubMed |
| 19 | 38658748 | PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells. | Nature | 2024 | https://conductscience.org/library/papers/38658748 | PubMed |
| 20 | 33627871 | Lipid signalling enforces functional specialization of Treg cells in tumours. | Nature | 2021 | https://conductscience.org/library/papers/33627871 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42266701 | Overcoming immunotherapy resistance in triple-negative breast cancer: a critical review of mast cell plasticity, metabolic reprogramming, and organoid models. | Front Immunol | 2026 | https://conductscience.org/library/papers/42266701 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41368640
GET https://conductscience.org/api/papers/v1/41368640/references?page=2